Optometrists in Blythe, CA Accepting Medicare
4 Optometrists found. Showing 1 - 4
 Blythe Eye Care Medical Group Optometrist Medicare: Not Enrolled in Medicare Practice Location: 600 E Hobson Way, Blythe, CA 92225 Phone: 760-922-0284 |
 Dr. Daniel Mark Judd, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 600 E Hobsonway, Blythe, CA 92225 Phone: 760-922-0284 |
Stuart Adams Od Pc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 110 N Spring St, Blythe, CA 92225 Phone: 760-922-3951 Fax: 760-922-5202 |
Timothy R Port Od Inc-ca Optometrist Medicare: Not Enrolled in Medicare Practice Location: 110 N Spring St, Blythe, CA 92225 Phone: 760-922-3951 Fax: 760-922-5202 |
News Archive
Tengion permits second patient enrollment in Neo-Urinary Conduit for bladder cancer
Tengion, Inc., a leader in regenerative medicine, announced today that the scheduled one-month, post-operative clinical assessment of the first implanted bladder cancer patient in its ongoing clinical trial has been completed as expected and has permitted the second patient to be enrolled without delay.
Republican Senators go on the offensive against reconciliation vote
Roll Call: Senate Republicans have stepped-up their message attack against President Barack Obama's latest push to pass health reform. "A key element of the Senate GOP's plan appears to be to try to scare House Democrats against voting for the health care plan, arguing that there's no guarantee that the Senate approves a reconciliation package."
AstraZeneca presents safety and efficacy data for ExQW at 51st Annual Meeting of EASD
AstraZeneca today announced new analyses of exenatide once weekly (ExQW) demonstrating a favorable gastrointestinal (GI) tolerability profile, including less frequent upper and lower GI adverse events (AE), compared to shorter-acting glucagon-like peptide-1 receptor agonists (GLP-1RA), exenatide twice daily (ExBID) and liraglutide once daily (LiraQD).
Pepsi Refresh grant helps in launching Rett syndrome drug development program
The International Rett Syndrome Foundation (IRSF) believes that accelerating the pace of meritorious research, supporting families, and raising awareness are the minimum effort necessary to successfully search for treatments and a cure for one of the most devastating neurological diseases to affect young girls. On October 1, IRSF became the recipient of a $250,000 grant from the Pepsi Refresh contest that was officially confirmed later in the month.
› Verified 5 days ago
Physical Therapists
Optometrists
Chiropractors
Speech-Language Pathologists